← Evidence map

ArticleFrontiers in neurology2024

Efgartigimod treatment in patients with anti-MuSK-positive myasthenia gravis in exacerbation.

Fangyi Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

10 papers cite it

2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 39628891